Ambalal Sarabhai FY26 Net Profit Rises to ₹1,780.32 Lakh
Ambalal Sarabhai Enterprises Limited reported a consolidated net profit of ₹1,780.32 lakh for the financial year ended March 31, 2026, a sharp rise from ₹493.17 lakh in the previous year. Revenue from operations grew to ₹20,227.17 lakh from ₹19,618.53 lakh in FY25. The Board recommended the re-appointment of Mr. Kartikeya V. Sarabhai as Executive Chairman and Mr. Mohal K. Sarabhai as Managing Director, among other key managerial decisions.
*this image is generated using AI for illustrative purposes only.
Ambalal Sarabhai Enterprises Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the standalone and consolidated financial results during its meeting held on May 21, 2026.
Consolidated Financial Performance
For the financial year ended March 31, 2026, the company reported a consolidated net profit of ₹1,780.32 lakh, a sharp rise from ₹493.17 lakh in the previous year. Revenue from operations grew to ₹20,227.17 lakh from ₹19,618.53 lakh in FY25. Total income for the year increased to ₹21,744.34 lakh. The profit before tax for the year stood at ₹1,850.64 lakh.
In the quarter ended March 31, 2026, the consolidated net profit was ₹650.11 lakh, compared to a loss of ₹26.70 lakh in the same period last year. Revenue from operations for the quarter was ₹6,548.73 lakh, while total income stood at ₹6,809.91 lakh.
| Metric | Year Ended March 31, 2026 (₹ in Lakhs) | Year Ended March 31, 2025 (₹ in Lakhs) |
|---|---|---|
| Revenue from Operations | 20,227.17 | 19,618.53 |
| Total Income | 21,744.34 | 20,757.02 |
| Total Expenses | 19,853.89 | 19,637.59 |
| Net Profit for the Period | 1,780.32 | 493.17 |
Standalone Results
On a standalone basis, the company reported a net profit of ₹1,099.09 lakh for the year ended March 31, 2026, compared to ₹824.18 lakh in the previous year. Revenue from operations for the year was ₹394.37 lakh. For the quarter ended March 31, 2026, the standalone net profit was ₹265.14 lakh.
Board Decisions and Appointments
The Board approved the re-appointment of M/s. Gautam Joshi & Co. as the internal auditor for FY 2026-27. Additionally, the Board recommended the re-appointment of Mr. Kartikeya V. Sarabhai as Executive Chairman for three years effective April 1, 2027, and Mr. Mohal K. Sarabhai as Managing Director for three years effective September 21, 2026. Ms. Chaula M. Shastri was also recommended for re-appointment as Whole-time Director for three years effective April 1, 2027.
The Board approved the continuation of Mr. Govindprasad Namdeo as a Non-Executive Independent Director upon attaining the age of 75 years. The 48th Annual General Meeting is scheduled to be held on July 30, 2026, via video conferencing. The Board also recommended granting inter-corporate loans to Asence Pharma Private Limited, Synbiotics Limited, and Systronics India Limited.
Historical Stock Returns for Ambalal Sarabhai Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.27% | +5.78% | +0.92% | +0.92% | +0.92% | +0.92% |
How might the inter-corporate loans to Asence Pharma, Synbiotics, and Systronics impact Ambalal Sarabhai's consolidated balance sheet and liquidity position in FY2027?
Given the significant gap between standalone revenue (₹394 lakh) and consolidated revenue (₹20,227 lakh), which subsidiaries are driving growth and could they sustain this momentum into FY2027?
With net profit nearly quadrupling year-over-year, what specific operational improvements or one-time gains contributed to this turnaround, and are they likely to be recurring?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
